|
1
|
Levy G, Hill MJ, Plowden TC, Catherino WH
and Armstrong AY: Biomarkers in uterine leiomyoma. Fertil Steril.
99:1146–1152. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bradley LD and Gueye NA: The medical
management of abnormal uterine bleeding in reproductive-aged women.
Am J Obstet Gynecol. 214:31–44. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Commandeur AE, Styer AK and Teixeira JM:
Epidemiological and genetic clues for molecular mechanisms involved
in uterine leiomyoma development and growth. Hum Reprod Update.
21:593–615. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marino JL, Eskenazi B, Warner M, Samuels
S, Vercellini P, Gavoni N and Olive D: Uterine leiomyoma and
menstrual cycle characteristics in a population-based cohort study.
Hum Reprod. 19:2350–2355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chabbert-Buffet N, Esber N and Bouchard P:
Fibroid growth and medical options for treatment. Fertil Steril.
102:630–639. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Donnez J, Donnez O and Dolmans MM: With
the advent of selective progesterone receptor modulators, what is
the place of myoma surgery in current practice? Fertil Steril.
102:640–648. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Makinen N, Mehine M, Tolvanen J, Kaasinen
E, Li Y, Lehtonen HJ, Gentile M, Yan J, Enge M, Taipale M, et al:
MED12, the mediator complex subunit 12 gene, is mutated at high
frequency in uterine leiomyomas. Science. 334:252–255. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mehine M, Kaasinen E, Mäkinen N, Katainen
R, Kämpjärvi K, Pitkänen E, Heinonen HR, Bützow R, Kilpivaara O,
Kuosmanen A, et al: Characterization of uterine leiomyomas by
whole-genome sequencing. N Engl J Med. 369:43–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Markowski DN, Bartnitzke S, Löning T,
Drieschner N, Helmke BM and Bullerdiek J: MED12 mutations in
uterine fibroids-their relationship to cytogenetic subgroups. Int J
Cancer. 131:1528–1536. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kämpjärvi K, Park MJ, Mehine M, Kim NH,
Clark AD, Bützow R, Böhling T, Böhm J, Mecklin JP, Järvinen H, et
al: Mutations in exon 1 highlight the role of MED12 in uterine
leiomyomas. Hum Mutat. 35:1136–1141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Di Tommaso S, Tinelli A, Malvasi A and
Massari S: Missense mutations in exon 2 of the MED12 gene are
involved in IGF-2 overexpression in uterine leiomyoma. Mol Hum
Reprod. 20:1009–1015. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Heinonen HR, Sarvilinna NS, Sjöberg J,
Kämpjärvi K, Pitkänen E, Vahteristo P, Mäkinen N and Aaltonen LA:
MED12 mutation frequency in unselected sporadic uterine leiomyomas.
Fertil Steril. 102:1137–1142. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lim WK, Ong CK, Tan J, Thike AA, Ng CC,
Rajasegaran V, Myint SS, Nagarajan S, Nasir ND, McPherson JR, et
al: Exome sequencing identifies highly recurrent MED12 somatic
mutations in breast fibroadenoma. Nat Genet. 46:877–880. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tan J, Ong CK, Lim WK, Ng CC, Thike AA, Ng
LM, Rajasegaran V, Myint SS, Nagarajan S and Thangaraju S: Genomic
landscapes of breast fibroepithelial tumors. Nat Genet.
47:1341–1345. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kämpjärvi K, Järvinen TM, Heikkinen T,
Ruppert AS, Senter L, Hoag KW, Dufva O, Kontro M, Rassenti L,
Hertlein E, et al: Somatic MED12 mutations are associated with poor
prognosis markers in chronic lymphocytic leukemia. Oncotarget.
6:1884–1888. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barbieri CE, Baca SC, Lawrence MS,
Demichelis F, Blattner M, Theurillat JP, White TA, Stojanov P, van
Allen E, Stransky N, et al: Exome sequencing identifies recurrent
SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet.
44:685–689. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kämpjärvi K, Kim NH, Keskitalo S, Clark
AD, von Nandelstadh P, Turunen M, Heikkinen T, Park MJ, Mäkinen N,
Kivinummi K, et al: Somatic MED12 mutations in prostate cancer and
uterine leiomyomas promote tumorigenesis through distinct
mechanisms. Prostate. 76:22–31. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kämpjärvi K, Mäkinen N, Kilpivaara O,
Arola J, Heinonen HR, Böhm J, Abdel-Wahab O, Lehtonen HJ, Pelttari
LM, Mehine M, et al: Somatic MED12 mutations in uterine
leiomyosarcoma and colorectal cancer. Br J Cancer. 107:1761–1765.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Knuesel MT, Meyer KD, Bernecky C and
Taatjes DJ: The human CDK8 subcomplex is a molecular switch that
controls Mediator coactivator function. Genes Dev. 23:439–451.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mittal P, Shin YH, Yatsenko SA, Castro CA,
Surti U and Rajkovic A: Med12 gain-of-function mutation causes
leiomyomas and genomic instability. J Clin Invest. 125:3280–3244.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan H, Parsons DW, Jin G, McLendon R,
Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ,
et al: IDH1 and IDH2 mutations in gliomas. N Engl J Med.
360:765–773. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zou Y, Zeng Y, Zhang DF, Zou SH, Cheng YF
and Yao YG: IDH1 and IDH2 mutations are frequent in Chinese
patients with acute myeloid leukemia but rare in other types of
hematological disorders. Biochem Biophys Res Commun. 402:378–383.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
van Raamsdonk CD, Griewank KG, Crosby MB,
Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green
G, Bouvier N, et al: Mutations in GNA11 in uveal melanoma. N Engl J
Med. 363:2191–2193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Clark K, Karsch-Mizrachi I, Lipman DJ,
Ostell J and Sayers EW: GenBank. Nucleic Acids Res. 44:D67–D72.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu X, Liu J, Zeng X, Lu F, Chen A and Huo
X: Elevated serum polybrominated diphenyl ethers and alteration of
thyroid hormones in children from Guiyu, China. PLoS One.
9:e1136992014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang W, Liu M, Wang J, Tian R, Dong J, Liu
Q, Zhao X and Wang Y: Analysis of the discriminative methods for
diagnosis of benign and malignant solitary pulmonary nodules based
on serum markers. Oncol Res Treat. 37:740–746. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Henare SJ, Kikuchi M, Talbot RT and
Cockrem JF: Changes in plasma gonadotrophins, 17β-oestradiol,
progesterone, prolactin, thyroxine and triiodothyronine
concentrations in female Japanese quail (Coturnix coturnix
japonica) of a heavy body weight line during photo-induced ovarian
growth and regression. Br Poult Sci. 53:520–530. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsubara A, Sekine S, Yoshida M, Yoshida
A, Taniguchi H, Kushima R, Tsuda H and Kanai Y: Prevalence of MED12
mutations in uterine and extrauterine smooth muscle tumours.
Histopathology. 62:657–661. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Osinovskaya NS, Malysheva OV, Shved NY,
Ivashchenko TE, Sultanov IY, Efimova OA, Yarmolinskaya MI, Bezhenar
VF and Baranov VS: Frequency and spectrum of MED12 exon 2 mutations
in multiple versus solitary uterine leiomyomas from Russian
patients. Int J Gynecol Pathol. 35:509–515. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shahbazi S, Fatahi N and Amini-Moghaddam
S: Somatic mutational analysis of MED12 exon 2 in uterine
leiomyomas of Iranian women. Am J Cancer Res. 5:2441–2446.
2015.PubMed/NCBI
|
|
31
|
Sadeghi S, Khorrami M, Amin-Beidokhti M,
Abbasi M, Kamalian Z, Irani S, Omrani M, Azmoodeh O and Mirfakhraie
R: The study of MED12 gene mutations in uterine leiomyomas from
Iranian patients. Tumour Biol. 37:1567–1571. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mehine M, Heinonen HR, Sarvilinna N,
Pitkänen E, Mäkinen N, Katainen R, Tuupanen S, Bützow R, Sjöberg J
and Aaltonen LA: Clonally related uterine leiomyomas are common and
display branched tumor evolution. Hum Mol Genet. 24:4407–4416.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang H, Ye J, Qian H, Zhou R, Jiang J and
Ye L: High-resolution melting analysis of MED12 mutations in
uterine leiomyomas in Chinese patients. Genet Test Mol Biomarkers.
19:162–166. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Halder SK, Laknaur A, Miller J, Layman LC,
Diamond M and Al-Hendy A: Novel MED12 gene somatic mutations in
women from the Southern United States with symptomatic uterine
fibroids. Mol Genet Genomics. 290:505–511. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Q, Ubago J, Li L, Guo H, Liu Y,
Qiang W, Kim JJ, Kong B and Wei JJ: Molecular analyses of 6
different types of uterine smooth muscle tumors: Emphasis in
atypical leiomyoma. Cancer. 120:3165–3177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bertsch E, Qiang W, Zhang Q,
Espona-Fiedler M, Druschitz S, Liu Y, Mittal K, Kong B, Kurita T
and Wei JJ: MED12 and HMGA2 mutations: Two independent genetic
events in uterine leiomyoma and leiomyosarcoma. Mod Pathol.
27:1144–1153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Makinen N, Vahteristo P, Kämpjärvi K,
Arola J, Bützow R and Aaltonen LA: MED12 exon 2 mutations in
histopathological uterine leiomyoma variants. Eur J Hum Genet.
21:1300–1303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ye J, Wang H, Chen YB, Yuan DL, Zhang LX
and Liu L: MED12 mutation in patients with hysteromyoma. Oncol
Lett. 9:2771–2774. 2015.PubMed/NCBI
|
|
39
|
Schwetye KE, Pfeifer JD and Duncavage EJ:
MED12 exon 2 mutations in uterine and extrauterine smooth muscle
tumors. Hum Pathol. 45:65–70. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
McGuire MM, Yatsenko A, Hoffner L, Jones
M, Surti U and Rajkovic A: Whole exome sequencing in a random
sample of North American women with leiomyomas identifies MED12
mutations in majority of uterine leiomyomas. PLoS One.
7:e332512012. View Article : Google Scholar : PubMed/NCBI
|
